Together with CCL22, which showed a 24-fold overexpression in CD11b+CD11c+ MDSCs, both chemokines are known to attract CCR4-bearing Th2 cells and serve as markers for the severity of Th2-mediated atopic dermatitis (42, 43). This evidence concerns the gene CCL22 and atopic eczema.